Phase 3 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were assigned male or female at birth
- People who are 18 years of age or older at the time of signing the consent form
- People who have previously been diagnosed with moderate-to-severe obstructive sleep apnea (a condition where breathing repeatedly stops during sleep), confirmed by a sleep study or approved testing method, with a certain level of breathing disruptions per hour (confirm with trial site for exact threshold)
Who may not be able to join:
- People whose blood sugar control levels (measured by a specific blood test called HbA1c) are at or above a certain threshold at the screening appointment, as measured by the trial laboratory
- People who have a personal history of type 1 or type 2 diabetes, either as reported by them or recorded in their medical records
- People who have had, or have planned, surgery for sleep apnea within the 90 days before screening — this includes certain nose, throat, or ear surgeries such as tonsil or adenoid removal
- People who have significant structural differences in the face or skull that may affect breathing
- People who have previously been treated with a class of medications known as GLP-1 receptor agonists, dual GLP-1/GIP receptor agonists, or similar GLP-1-based treatments, or a medication type called amylin analogues, before the screening appointment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Transparency dept. 2834, Novo Nordisk A/S
Phone: (+1) 866-867-7178
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
5 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Relative change in body weight; Change in apnoea-hypopnoea index (AHI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.